Published in Cancer Weekly, February 14th, 2006
In October 2005, Armstrong was appointed to serve as interim CEO and president commencing January 1, 2006.
"We are so pleased that Jack has agreed to serve as CEO of Genaera," said Zola P. Horovitz, PhD, Lead director of the board of directors of Genaera. "Jack has a proven track record with the company and has made outstanding contributions in terms of focusing the business and streamlining the clinical process for our lead product EVIZON. This progress and commitment, added to his broad industry...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.